Ovarian Tumours (with Comments on Fallopian Tube)

  • Rajeev ShahEmail author
  • Aaron Ervine


Ovarian Carcinoma (with comments on Fallopian Tube Carcinoma): this chapter outlines the incidence, risk factors, clinical presentation, investigations, treatments and prognosis of cancer at this anatomical site. These features are correlated with the core data that are required to make corresponding histopathology reports of a consistently high quality, available in an appropriate timeframe, and clinically relevant to patient management and prognosis. Summary details of the common cancers given at this site include: gross description, histological types, tumour grade/differentiation, extent of local tumour spread, lymphovascular invasion, lymph node involvement, and the status of excision margins. Current WHO Classifications of Malignant Tumours and TNM8/FIGO are referenced. Notes are provided on other associated pathology, contemporary use of immunohistochemistry, updates on the role of evolving molecular tests, and the use of these ancillary techniques as biomarkers in diagnosis, and prediction of prognosis and treatment response. A summary is given of the more common non-carcinoma malignancies that are encountered at this site in diagnostic practice.


Fallopian Tube Serous Carcinoma High grade serous carcinoma Endometrioid carcinoma Pseudomyxoma peritonei BRCA FIGO 


  1. Al-Nafussi A. Ovarian epithelial tumours: common problems in diagnosis. Curr Diagn Pathol. 2004;10:473–99.CrossRefGoogle Scholar
  2. Carlson J, Roh MH, Chang MC, Crum CP. Recent advances in the understanding of the pathogenesis of serous carcinoma: the concept of low- and high-grade disease and the role of the fallopian tube. Diagn Histopathol. 2008;14:352–65.CrossRefGoogle Scholar
  3. Deen S, Thomson AM, Al-Nafussi A. Histopathological challenges in assessing borderline ovarian tumours. Curr Diagn Pathol. 2006;12:325–46.CrossRefGoogle Scholar
  4. DeLair D, Soslow RA. Key features of extrauterine pelvic serous tumours (fallopian tube, ovary, and peritoneum). Histopathology. 2012;61:329–39.CrossRefGoogle Scholar
  5. Folkins AK, Longacre TA. Hereditary gynaecological malignancies: advances in screening and treatment. Histopathology. 2013;62:2–30.CrossRefGoogle Scholar
  6. Fox H, Wells M, editors. Haines and Taylor. Obstetrical and gynaecological pathology. 5th ed. London: Churchill Livingstone; 2003.Google Scholar
  7. Gurung A, Hung T, Morin J, Gilks CB. Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates. Histopathology. 2013;62:59–70.CrossRefGoogle Scholar
  8. Heatley MK. Dissection and reporting of the organs of the female genital tract. J Clin Pathol. 2008;61:241–57.CrossRefGoogle Scholar
  9. Herrington CS. Recent advances in molecular gynaecological pathology. Histopathology. 2009;55:243–9.CrossRefGoogle Scholar
  10. Kasprzak L, Foulkes WD, Shelling AN. Hereditary ovarian carcinoma. BMJ. 1999;318:786–9.CrossRefGoogle Scholar
  11. Khoo U-S, Shen D-H, Wong RW-C, Cheung AN-Y. Gynaecological cancers in genetically susceptible women: new thoughts on tubal pathology. Diagn Histopathol. 2009;15:545–9.CrossRefGoogle Scholar
  12. Kurman RJ, Seidman JD, Shih IM. Serous borderline tumours of the ovary. Histopathology. 2005;47:310–8.CrossRefGoogle Scholar
  13. Leen LMS, Singh N. Pathology of primary and metastatic mucinous ovarian neoplasms. J Clin Pathol. 2012;65:591–5.CrossRefGoogle Scholar
  14. Lerwill MF, Young RH. Mucinous tumours of the ovary. Diagn Histopathol. 2008;14:366–87.CrossRefGoogle Scholar
  15. McCluggage WG. My approach to and thoughts on the typing of ovarian carcinomas. J Clin Pathol. 2008a;61:152–63.CrossRefGoogle Scholar
  16. McCluggage WG. Immunohistochemical markers as a diagnostic aid in ovarian pathology. Diagn Histopathol. 2008b;14:335–51.CrossRefGoogle Scholar
  17. McCluggage WG. Ten problematic issues identified by pathology review for multidisciplinary gynaecological oncology meetings. J Clin Pathol. 2012a;65:293–301.CrossRefGoogle Scholar
  18. McCluggage WG. Immunohistochemistry in the distinction between primary and metastatic ovarian mucinous neoplasms. J Clin Pathol. 2012b;65:596–600.CrossRefGoogle Scholar
  19. McCluggage WG, Hirschowitz L, Ganesan R, Kehoe S, Nordin A. Which staging system to use for gynaecological cancers: a survey with recommendations for practice in the UK. J Clin Pathol. 2010;63:768–70.CrossRefGoogle Scholar
  20. McCluggage WG, Wilkinson N. Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features. Histopathology. 2005;47:231–47.CrossRefGoogle Scholar
  21. Miller K, McCluggage WG. Prognostic factors in ovarian adult granulosa cell tumour. J Clin Pathol. 2008;61:881–4.CrossRefGoogle Scholar
  22. Rabban JT, Zaloudek CJ. A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours. Histopathology. 2013;62:71–88.CrossRefGoogle Scholar
  23. Redman C, Duffy S, Bromham M, Francis K, on behalf of the Guideline Development Group. Recognition and initial management of ovarian cancer: summary of NICE guidance. BMJ. 2011;342:973–5.CrossRefGoogle Scholar
  24. Robboy SJ, Bentley RC, Russell R, Anderson MC, Mutter GL, Prat J. Pathology of the female reproductive tract. 2nd ed. London: Churchill Livingstone Elsevier; 2009.Google Scholar
  25. Roth LM. Two-tier grading system for ovarian epithelial cancer. Has its time arrived? Am J Surg Pathol. 2007;31:1285–7.CrossRefGoogle Scholar
  26. Russell P, Farnsworth A. Surgical pathology of the ovaries. 2nd ed. London: Churchill Livingstone; 1997.Google Scholar
  27. Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube and broad ligament. Atlas of tumor pathology, vol. 3. Washington, DC: AFIP; 1998.Google Scholar
  28. Singh N. Synchronous tumours of the female genital tract. Histopathology. 2010;56:277–85.CrossRefGoogle Scholar
  29. Stewart CJR, McCluggage WG. Epithelial-mesenchymal transition in carcinomas of the female genital tract. Histopathology. 2013;62:31–43.CrossRefGoogle Scholar
  30. Tavassoli F, Devilee P. WHO classification of tumours. Pathology and genetics. Tumours of the breast and female genital organs. Lyon: IARC Press; 2003.Google Scholar
  31. The Royal College of Pathologists. Cancer datasets (vulval neoplasms, cervical neoplasia, endometrial cancer, uterine sarcomas, neoplasms of the ovaries and fallopian tubes and primary carcinoma of the peritoneum), and tissue pathways for gynaecological pathology. 2015.
  32. Vang R, Shih IM, Kurman RJ. Fallopian tube precursors of ovarian low- and high-grade serous neoplasms. Histopathology. 2013;62:44–58.CrossRefGoogle Scholar
  33. Wilkinson N, Osborn S, Young RH. Sex cord-stromal tumours of the ovary: a review highlighting recent advances. Diagn Histopathol. 2008;14:388–400.CrossRefGoogle Scholar
  34. Willmott F, Allouni KA, Rockall A. Radiological manifestations of metastasis to the ovary. J Clin Pathol. 2012;65:585–90.CrossRefGoogle Scholar
  35. Young RH, Gilks CB, Scully RE. Mucinous tumors of the appendix associated with mucinous tumors of the ovary and pseudomyxoma peritonei: a clinicopathologic analysis of 22 cases supporting an origin in the appendix. Am J Surg Pathol. 1991;15:415–29.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Cellular PathologyCraigavon Area HospitalCraigavonUK

Personalised recommendations